The public often turns to science for accurate health information, which, in an ideal world, would be error free. However, limitations of scientific institutions and scientific processes can sometimes amplify misinformation and disinformation. The current review examines four mechanisms through which this occurs: (1) predatory journals that accept publications for monetary gain but do not engage in rigorous peer review; (2) pseudoscientists who provide scientific-sounding information but whose advice is inaccurate, unfalsifiable, or inconsistent with the scientific method; (3) occasions when legitimate scientists spread misinformation or disinformation; and (4) miscommunication of science by the media and other communicators. We characterize this article as a "call to arms," given the urgent need for the scientific information ecosystem to improve. Improvements are necessary to maintain the public's trust in science, foster robust discourse, and encourage a well-educated citizenry.
Since December 2019, the world has faced an unprecedented pandemic crisis due to a new coronavirus disease, coronavirus disease-2019 (COVID-19), which has instigated intensive studies on prevention and treatment possibilities. Here, we investigate the relationships between the immune activation induced by three coronaviruses associated with recent outbreaks, with special attention to SARS-CoV-2, the causative agent of COVID-19, and the immune activation induced by carbon nanotubes (CNTs) to understand the points of convergence in immune induction and modulation. Evidence suggests that CNTs are among the most promising materials for use as immunotherapeutic agents. Therefore, this investigation explores new possibilities of effective immunotherapies for COVID-19. This study aimed to raise interest and knowledge about the use of CNTs as immunotherapeutic agents in coronavirus treatment. Thus, we summarize the most important immunological aspects of various coronavirus infections and describe key advances and challenges in using CNTs as immunotherapeutic agents against viral infections and the activation of the immune response induced by CNTs, which can shed light on the immunotherapeutic possibilities of CNTs.